Suchergebnisse - "Bisbal, Otilia"

PubPharm (16)

1

Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Suárez-García, I. | Alejos, B. | Hernando, V. | +111

2

Integrase inhibitors in children and adolescents : clinical use and resistance

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Torres-Fernandez, D. | Jiménez de Ory, S. | Fortuny, C. | +111

3

Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors : A Spanish nationwide cohort

enthalten in: HIV medicine | 2022

von Álvarez, H. | Rava, M. | Martínez, C. | +108

4

Use of Generic Antiretroviral Drugs and Single-Tablet Regimen De-Simplification for the Treatment of HIV Infection in Spain

enthalten in: AIDS research and human retroviruses | 2022

von Ruiz-Algueró, M. | Alejos, B. | García Yubero, C. | +110

5

Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens

enthalten in: Frontiers in immunology | 2022

von Serrano-Villar, S. | López-Huertas, M. | Jiménez, D. | +12

CommentIn: Front Immunol. 2022 Apr 29;13:904689. - PMID 35572577

6

Detection of archived lamivudine-associated resistance mutations in virologically suppressed, lamivudine-experienced HIV-infected adults by different genotyping techniques (GEN-PRO study)

enthalten in: The Journal of antimicrobial chemotherapy | 2021

von Montejano, R. | Dominguez-Dominguez, L. | de Miguel, R. | +19

7

COVID-19 in hospitalized HIV-positive and HIV-negative patients : A matched study

enthalten in: HIV medicine | 2021

von Díez, C. | Del Romero-Raposo, J. | Mican, R. | +117

8

Late presentation for HIV impairs immunological but not virological response to antiretroviral treatment

enthalten in: AIDS (London, England) | 2021

von Rava, M. | Bisbal, O. | Domínguez-Domínguez, L. | +11

9

Prevalence of M184V and K65R in proviral DNA from PBMCs in HIV-infected youths with lamivudine/emtricitabine exposure

enthalten in: The Journal of antimicrobial chemotherapy | 2021

von Jiménez de Ory, S. | Beltrán-Pavez, C. | Gutiérrez-López, M. | +112

10

Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine : Week 96 results of ART-PRO pilot study

enthalten in: The Journal of antimicrobial chemotherapy | 2021

von Rial-Crestelo, D. | de Miguel, R. | Montejano, R. | +52